Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Specter Spares Supplements, Hammers DEA Over Illegal Steroid Products

This article was originally published in The Tan Sheet

Executive Summary

A Senate Judiciary subcommittee hearing on "hidden steroids" in bodybuilding products sold as supplements took the Drug Enforcement Administration to task for a delay on restricting access to anabolic steroids
Advertisement

Related Content

Fabricant Will Helm FDA Dietary Supplement Office
Sen. Hatch Offers Strategies For Thwarting Growing DSHEA Threats
Future DSHEA Challengers Will Learn From McCain Bill Failure - NPA
GAO New Dietary Ingredient Probe Has Puzzled Firms Seeking Legal Advice
Guilty Plea In VMG Steroid Case Weighs On Firm, Not DSHEA Critics
NPA Chief Looks To Expand The Industry's "Toolbox For Advocacy"
Industry Must Step Up Now To Save DSHEA, Wellness Opportunities - Experts
Sharfstein Says Spiked Products Top FDA Supplement Enforcement Goals
Supplement Industry Must Pony Up To Ride "Difficult Road" On Capitol Hill
CRN Stands Up Against U.S. Sports Official's Criticism Of Supplement Quality

Topics

Advertisement
UsernamePublicRestriction

Register

PS103397

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel